# Biomarkers of Iron Homeostasis and Responses to Cystic Fibrosis Pulmonary Exacerbation (CFPE) Treatment

> **NCT02188758** · — · COMPLETED · sponsor: **Dartmouth-Hitchcock Medical Center** · enrollment: 20 (actual)

## Conditions studied

- Cystic Fibrosis

## Interventions

- **OTHER:** Adults - CFPE Treatment

## Key facts

- **NCT ID:** NCT02188758
- **Lead sponsor:** Dartmouth-Hitchcock Medical Center
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2014-07
- **Primary completion:** 2017-12
- **Final completion:** 2018-01
- **Target enrollment:** 20 (ACTUAL)
- **Last updated:** 2018-03-13

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02188758

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02188758, "Biomarkers of Iron Homeostasis and Responses to Cystic Fibrosis Pulmonary Exacerbation (CFPE) Treatment". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02188758. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
